Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
ANXA1 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
g O-GlcNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
ANXA1 a calcium/phospholipid-binding protein with which promotes membrane fusion and is involved in endocytosis. Has anti-inflammatory properties and inhibits phospholipase A2 activity. Accumulates on internalized vesicles after EGF-stimulated endocytosis, suggesting that it may be required for a late stage in inward vesiculation. Phosphorylated by PKC, EGFR and Chak1. Phosphorylation results in loss of the inhibitory activity. Annexins are a family of structurally related proteins whose common property is calcium-dependent binding to phospholipids. There are at least ten different annexins in mammalian species. Annexins do not contain signal peptides, yet some annexins (A1, A2 and A5) appear to be secreted in a physiologically regulated fashion. Note: This description may include information from UniProtKB.
Protein type: Lipid binding protein; Calcium-binding protein
Cellular Component: extracellular space; protein complex; basolateral plasma membrane; cytoplasm; mitochondrial membrane; extracellular region; plasma membrane; cornified envelope; nucleus; sarcolemma; cilium
Molecular Function: protein binding, bridging; protein binding; single-stranded RNA binding; protein homodimerization activity; calcium-dependent phospholipid binding; phospholipase A2 inhibitor activity; phospholipid binding; calcium ion binding; structural molecule activity; single-stranded DNA binding; receptor binding
Biological Process: response to peptide hormone stimulus; positive regulation of apoptosis; alpha-beta T cell differentiation; positive regulation of vesicle fusion; signal transduction; response to estradiol stimulus; estrous cycle phase; cell surface receptor linked signal transduction; inflammatory response; response to X-ray; positive regulation of prostaglandin biosynthetic process; response to drug; negative regulation of protein secretion; gliogenesis; negative regulation of acute inflammatory response; cell cycle; neutrophil homeostasis; arachidonic acid secretion; endocrine pancreas development; regulation of cell proliferation; keratinocyte differentiation; insulin secretion; peptide cross-linking; cell motility; negative regulation of apoptosis
Reference #:  P04083 (UniProtKB)
Alt. Names/Synonyms: Annexin A1; Annexin I; annexin I (lipocortin I); Annexin-1; ANX1; ANXA1; Calpactin II; Calpactin-2; Chromobindin-9; Lipocortin I; LPC1; p35; Phospholipase A2 inhibitory protein
Gene Symbols: ANXA1
Molecular weight: 38,714 Da
Basal Isoelectric point: 6.57  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

ANXA1
Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  RCSB PDB  |  Phospho3D  |  DISEASE  |  Source  |  UCSD-Nature  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Sites Implicated In
cytoskeletal reorganization: S27‑p
exocytosis, altered: S27‑p, S45‑p
intracellular localization: Y21‑p, S27‑p, S28‑p, S45‑p
molecular association, regulation: S5‑p
protein conformation: S5‑p

Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


  MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


        human

 
2 3 S5-p ___MAMVsEFLKQAW
0 1 K9 AMVsEFLKQAWFIEN
3 172 Y21-p IENEEQEyVQTVkss
1 0 T24 EEQEyVQTVksskGG
0 5 K26-u QEyVQTVksskGGPG
4 0 S27-p EyVQTVksskGGPGs
2 0 S28-p yVQTVksskGGPGsA
0 12 K29 VQTVkssKGGPGsAV
0 2 K29-u VQTVksskGGPGsAV
1 4 S34-p sskGGPGsAVsPyPt
0 13 S37-p GGPGsAVsPyPtFNP
0 201 Y39-p PGsAVsPyPtFNPsS
0 5 T41-p sAVsPyPtFNPsSDV
1 0 S45-p PyPtFNPsSDVAALH
0 1 K53-a SDVAALHkAIMVkGV
0 3 K53-u SDVAALHkAIMVkGV
0 7 K58-u LHkAIMVkGVDEAtI
0 1 T64-p VkGVDEAtIIDILtk
0 1 T70-p AtIIDILtkRNNAQR
0 3 K71-a tIIDILtkRNNAQRQ
0 2 K71-u tIIDILtkRNNAQRQ
0 1 K81-u NAQRQQIkAAyLQEt
0 14 Y84-p RQQIkAAyLQEtGkP
0 1 T88-p kAAyLQEtGkPLDET
0 2 K90-a AyLQEtGkPLDETLk
0 1 K90-u AyLQEtGkPLDETLk
0 65 K97-a kPLDETLkkALTGHL
0 1 K97-u kPLDETLkkALTGHL
0 2 K98-a PLDETLkkALTGHLE
0 1 K98-u PLDETLkkALTGHLE
0 4 K128-u DELRAAMkGLGTDED
0 16 K161-a RVYREELkRDLAkDI
0 4 K166-u ELkRDLAkDItsDts
0 2 T169-p RDLAkDItsDtsGDF
0 4 S170-p DLAkDItsDtsGDFR
0 2 T172-p AkDItsDtsGDFRNA
0 3 S173-p kDItsDtsGDFRNAL
0 2 K185-u NALLSLAkGDRSEDF
0 547 Y207-p DSDARALyEAGERRk
0 1 K214-u yEAGERRkGtDVNVF
2 1 T216-p AGERRkGtDVNVFNT
0 1 T226-p NVFNTILtTRSyPQL
0 1 Y230-p TILtTRSyPQLRRVF
0 4 K239-a QLRRVFQkyTKYSKH
0 1 Y240-p LRRVFQkyTKYSKHD
0 1 K250-a YSKHDMNkVLDLELk
0 1 K250-u YSKHDMNkVLDLELk
0 7 K257-u kVLDLELkGDIEKCL
0 1 T272 TAIVKCATSkPAFFA
0 5 K274-u IVKCATSkPAFFAEk
0 3 K281-a kPAFFAEkLHQAMkG
0 2 K281-u kPAFFAEkLHQAMkG
0 4 K287-u EkLHQAMkGVGTRHK
0 32 K312-a EIDMNDIkAFYQKMY
0 1 K312-u EIDMNDIkAFYQKMY
0 5 K332-u QAILDETkGDyEkIL
0 1 Y335-p LDETkGDyEkILVAL
0 1 K337-u ETkGDyEkILVALCG
  mouse

 
S5-p ___MAMVsEFLkQAR
K9-a AMVsEFLkQARFLEN
Y21-p LENQEQEyVQAVksY
A24 QEQEyVQAVksYkGG
K26-u QEyVQAVksYkGGPG
S27-p EyVQAVksYkGGPGs
Y28 yVQAVksYkGGPGsA
K29-a VQAVksYkGGPGsAV
K29 VQAVksYKGGPGsAV
S34-p sYkGGPGsAVsPYPS
S37-p GGPGsAVsPYPSFNV
Y39 PGsAVsPYPSFNVSS
S41 sAVsPYPSFNVSSDV
S45 PYPSFNVSSDVAALH
K53 SDVAALHKAIMVKGV
K53 SDVAALHKAIMVKGV
K58 LHKAIMVKGVDEATI
T64 VKGVDEATIIDILTk
T70 ATIIDILTkRTNAQR
K71-a TIIDILTkRTNAQRQ
K71 TIIDILTKRTNAQRQ
K81 NAQRQQIKAAYLQEN
Y84 RQQIKAAYLQENGKP
N88 KAAYLQENGKPLDEV
K90 AYLQENGKPLDEVLR
K90 AYLQENGKPLDEVLR
R97 KPLDEVLRKALTGHL
R97 KPLDEVLRKALTGHL
K98 PLDEVLRKALTGHLE
K98 PLDEVLRKALTGHLE
K128-u DELRGAMkGLGTDED
K161-a RVYREELkRDLAkDI
K166-u ELkRDLAkDITSDTs
T169 RDLAkDITSDTsGDF
S170 DLAkDITSDTsGDFR
T172 AkDITSDTsGDFRKA
S173-p kDITSDTsGDFRKAL
K185 KALLALAKGDRCQDL
Y207-p DTDARALyEAGERRK
K214 yEAGERRKGTDVNVF
T216 AGERRKGTDVNVFTT
T226 NVFTTILTSRSFPHL
F230 TILTSRSFPHLRRVF
N239 HLRRVFQNYGKYSQH
Y240 LRRVFQNYGKYSQHD
K250 YSQHDMNKALDLELK
K250 YSQHDMNKALDLELK
K257 KALDLELKGDIEKCL
T272-p TTIVKCAtSTPAFFA
T274 IVKCAtSTPAFFAEK
K281 TPAFFAEKLYEAMKG
K281 TPAFFAEKLYEAMKG
K287 EKLYEAMKGAGTRHK
K312-a EIDMNEIkVFYQKKY
K312 EIDMNEIKVFYQKKY
K332 QAILDETKGDYEKIL
Y335 LDETKGDYEKILVAL
K337 ETKGDYEKILVALCG
  rat

 
S5 ___MAMVSEFLKQAC
K9 AMVSEFLKQACYIEK
Y21-p IEKQEQEyVQAVKSY
A24 QEQEyVQAVKSYKGG
K26 QEyVQAVKSYKGGPG
S27 EyVQAVKSYKGGPGS
Y28 yVQAVKSYKGGPGSA
K29 VQAVKSYKGGPGSAV
K29 VQAVKSYKGGPGSAV
S34 SYKGGPGSAVSPYPS
S37 GGPGSAVSPYPSFNP
Y39 PGSAVSPYPSFNPSS
S41 SAVSPYPSFNPSSDV
S45 PYPSFNPSSDVAALH
K53 SDVAALHKAIMVKGV
K53 SDVAALHKAIMVKGV
K58 LHKAIMVKGVDEATI
T64 VKGVDEATIIDILTK
T70 ATIIDILTKRTNAQR
K71 TIIDILTKRTNAQRQ
K71 TIIDILTKRTNAQRQ
K81 NAQRQQIKAAYLQET
Y84 RQQIKAAYLQETGKP
T88 KAAYLQETGKPLDET
K90 AYLQETGKPLDETLK
K90 AYLQETGKPLDETLK
K97 KPLDETLKKALTGHL
K97 KPLDETLKKALTGHL
K98 PLDETLKKALTGHLE
K98 PLDETLKKALTGHLE
K128 DELRAAMKGLGTDED
K161 RVYREELKRDLAKDI
K166 ELKRDLAKDITSDTS
T169 RDLAKDITSDTSGDF
S170 DLAKDITSDTSGDFR
T172 AKDITSDTSGDFRNA
S173 KDITSDTSGDFRNAL
K185 NALLALAKGDRCEDM
Y207 DTDARALYEAGERRK
K214 YEAGERRKGtDVNVF
T216-p AGERRKGtDVNVFNT
T226 NVFNTILTTRSYPHL
Y230 TILTTRSYPHLRKVF
N239 HLRKVFQNYRKYSQH
Y240 LRKVFQNYRKYSQHD
K250 YSQHDMNKALDLELK
K250 YSQHDMNKALDLELK
K257 KALDLELKGDIEKCL
T272 TTIVKCATSTPAFFA
T274 IVKCATSTPAFFAEK
K281 TPAFFAEKLYEAMKG
K281 TPAFFAEKLYEAMKG
K287 EKLYEAMKGAGTRHK
K312 EIDMNEIKVFYQKKY
K312 EIDMNEIKVFYQKKY
K332 QAILDETKGDYEKIL
Y335 LDETKGDYEKILVAL
K337 ETKGDYEKILVALCG
  cow

 
S5-p ___MAMVsEFLKQAW
K9 AMVsEFLKQAWFIEN
Y21 IENEEQEYIKtVKGs
T24-p EEQEYIKtVKGsKGG
K26 QEYIKtVKGsKGGPG
G27 EYIKtVKGsKGGPGS
S28-p YIKtVKGsKGGPGSA
K29 IKtVKGsKGGPGSAV
K29 IKtVKGsKGGPGSAV
S34 GsKGGPGSAVSPYPT
S37 GGPGSAVSPYPTFNP
Y39 PGSAVSPYPTFNPSS
T41 SAVSPYPTFNPSSDV
S45 PYPTFNPSSDVEALH
K53 SDVEALHKAITVKGV
K53 SDVEALHKAITVKGV
K58 LHKAITVKGVDEATI
T64 VKGVDEATIIEILTK
T70 ATIIEILTKRNNAQR
K71 TIIEILTKRNNAQRQ
K71 TIIEILTKRNNAQRQ
K81 NAQRQQIKAAYLQEK
Y84 RQQIKAAYLQEKGKP
K88 KAAYLQEKGKPLDEV
K90 AYLQEKGKPLDEVLK
K90 AYLQEKGKPLDEVLK
K97 KPLDEVLKKALLGHL
K97 KPLDEVLKKALLGHL
K98 PLDEVLKKALLGHLE
K98 PLDEVLKKALLGHLE
K128 EELRAAMKGLGTDED
K161 RVYREELKRDLAKDI
K166 ELKRDLAKDIASDTS
A169 RDLAKDIASDTSGDY
S170 DLAKDIASDTSGDYE
T172 AKDIASDTSGDYEKA
S173 KDIASDTSGDYEKAL
K185 KALLSLAKGDRSEEL
Y207 DSDARALYEAGERRK
K214 YEAGERRKGTDVNVF
T216 AGERRKGTDVNVFIT
T226 NVFITILTTRSYPHL
Y230 TILTTRSYPHLRRVF
K239 HLRRVFQKYSKYSKH
Y240 LRRVFQKYSKYSKHD
K250 YSKHDMNKVLDLELK
K250 YSKHDMNKVLDLELK
K257 KVLDLELKGDIEKCL
T272 TVIVKCATSQPMFFA
Q274 IVKCATSQPMFFAEK
K281 QPMFFAEKLHQAMKG
K281 QPMFFAEKLHQAMKG
K287 EKLHQAMKGIGTRHK
K312 EIDMNDIKACYQKLY
K312 EIDMNDIKACYQKLY
K332 QAILDETKGDYEKIL
Y335 LDETKGDYEKILVAL
K337 ETKGDYEKILVALCG
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.